# A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

> clinical trial · VERIFIED · 2026-08-05

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05091424

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.